ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 706,89
0,00%
Dow Jones
39 411,21
0,67%
DAX
18 325,58
0,77%
Brent Oil
85,295
0,03%
Bitcoin
61 280,11
1,69%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Statera BioPharma Inc (STAB)

  7. Statera BioPharma Inc (STAB) Actualités

STAB

Statera BioPharma (STAB)

Statera BioPharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:STAB
DateHeureSourceTitreSymboleSociété
15/03/202313h00GlobeNewswire Inc.Statera Biopharma Signs Letter of Intent for Merger with Worksite LabsNASDAQ:STABStatera BioPharma Inc
03/03/202316h47Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:STABStatera BioPharma Inc
27/02/202312h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:STABStatera BioPharma Inc
15/02/202315h10Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:STABStatera BioPharma Inc
01/02/202322h35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
01/02/202322h10Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:STABStatera BioPharma Inc
14/11/202223h53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:STABStatera BioPharma Inc
06/10/202212h01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:STABStatera BioPharma Inc
23/09/202212h02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:STABStatera BioPharma Inc
26/08/202213h49GlobeNewswire Inc.Nasdaq Resumes Trading in Statera Biopharma, Inc.NASDAQ:STABStatera BioPharma Inc
25/08/202217h48GlobeNewswire Inc.Nasdaq Halts Statera Biopharma, Inc.NASDAQ:STABStatera BioPharma Inc
14/06/202213h30GlobeNewswire Inc.Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting FirmNASDAQ:STABStatera BioPharma Inc
23/05/202222h05GlobeNewswire Inc.Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-Q FilingNASDAQ:STABStatera BioPharma Inc
13/05/202213h30GlobeNewswire Inc.Statera Biopharma and Lay Sciences Inc. Announce Intent to Enter Strategic Partnership to License the Manufacturing Rights to Certain Lay Sciences IgY ProductsNASDAQ:STABStatera BioPharma Inc
27/04/202222h10GlobeNewswire Inc.Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose NaltrexoneNASDAQ:STABStatera BioPharma Inc
22/04/202223h26GlobeNewswire Inc.Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K FilingNASDAQ:STABStatera BioPharma Inc
13/04/202222h05GlobeNewswire Inc.Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to EntolimodNASDAQ:STABStatera BioPharma Inc
13/04/202213h00PR Newswire (US)Coeptis Therapeutics Announces Intent to Acquire TLR5 Agonist Platform, Including Clinical-Stage Asset Entolimod, from Statera BiopharmaNASDAQ:STABStatera BioPharma Inc
31/03/202222h05GlobeNewswire Inc.Statera Biopharma, Inc. Files Form 12b-25NASDAQ:STABStatera BioPharma Inc
28/03/202213h30GlobeNewswire Inc.Statera Biopharma, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 31, 2022NASDAQ:STABStatera BioPharma Inc
24/03/202222h28GlobeNewswire Inc.Statera Biopharma Announces Closing of $5.7 Million Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
22/03/202214h29GlobeNewswire Inc.Statera Biopharma Announces Pricing of $5.7 Million Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
22/03/202212h38GlobeNewswire Inc.CORRECTION -- Statera Biopharma Announces Proposed Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
22/03/202212h34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:STABStatera BioPharma Inc
22/03/202200h27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:STABStatera BioPharma Inc
21/03/202221h50GlobeNewswire Inc.Statera Biopharma Announces Proposed Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
08/03/202222h15GlobeNewswire Inc.Statera Biopharma Announces Revised Preliminary Revenue and Financial Results of Fiscal Year 2021NASDAQ:STABStatera BioPharma Inc
07/03/202213h30GlobeNewswire Inc.Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 PlatformNASDAQ:STABStatera BioPharma Inc
02/03/202215h08GlobeNewswire Inc.CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19NASDAQ:STABStatera BioPharma Inc
02/03/202213h30GlobeNewswire Inc.Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19NASDAQ:STABStatera BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:STAB

Dernières Valeurs Consultées

BIT
I09602
IT0005563363 20240621 22...
AMEX
BIZD
VanEck BDC Income ETF
BIT
P216B5
NLBNPIT216B5 20241220 100
BIT
P1ZZD9
NLBNPIT1ZZD9 20240920 40
USOTC
CRCCY
CRRC (PK)
EU
A778T
A778T
UNSW3
NKNUSDT
NKN [Ethereum]
NASDAQ
HDS
HD Supply
BOV
AMAR3F
LOJAS MARISA ON
BOV
CEAB3F
C&A ON
TG
NRD
Nordstrom
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés